Welcome to Waterland
Waterland is an independent private equity investment group that supports entrepreneurs in realizing their growth ambitions. With substantial financial resources and committed industry expertise, Waterland enables its portfolio companies to achieve accelerated growth both organically and through acquisitions. Waterland is an active investor in the financial, strategic and operational sense.
In the current dynamic business environment with an increasing number of (cross border) mergers and acquisitions, Waterland is a partner that provides entrepreneurs with a powerful position in the increasingly competitive international arena. In the meantime Waterland has made investments in over 300 companies. Waterland currently has € 2,5 billion of equity. In addition, Waterland has access to extensive leveraged finance funding.
Waterland is member of the Dutch Venture Capital Association (NVP), the Belgian Venturing Association (BVA), the European Private Equity & Venture Capital Association (EVCA), the German Private Equity and Venture Capital Association e.V. (BVK), Polskie Stowarzyszenie Inwestorow Kapitalowych (PSIK) and the Swiss Private Equity & Corporate Finance Association (SECA).
Waterland has offices in Bussum (The Netherlands), Antwerp (Belgium), Düsseldorf and Munich (Germany) and Warsaw (Poland).
Bussum, 29 December 2014 – Waterland Private Equity Investments B.V. has announced that it received a permit on 15 December 2014 to manage an investment institution as defined in Article 1.1 of the Financial Supervision Act.
Waterland Private Equity Investments B.V. (“Waterland”) has announced that it has received a permit on 15 December 2014 to manage an investment institution as defined in Article 1.1 of the Financial Supervision Act. This is the so-called AIFMD permit, which is mandatory for alternative investment fund managers in Europe with assets of more than €500M under management. Waterland has appointed Orangefield Nederland as the depositary for the private equity funds that Waterland manages (Waterland Private Equity Fund IV and Waterland Private Equity Fund V). Clifford Chance advised Waterland throughout the process of obtaining the permit.
About Orangefield Group
Orangefield is a financial services provider that operates throughout the world. It has a trust licence that is monitored by De Nederlandsche Bank (DNB). At the beginning of 2014, Orangefield was one of the first organisations in the Netherlands to obtain approval from the Netherlands Authority for the Financial Markets (AFM) for taking on the role of depositary. In the role of a depositary, Orangefield is now responsible for about 7 billion euros of capital belonging to both private equity funds and property funds.
Dublin, Ireland — (November 6, 2014) — Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of “Quality Affordable Healthcare Products®,” and Omega Pharma NV, one of the largest OTC healthcare companies in Europe, headquartered in Nazareth, Belgium, today announced that they have entered into a definitive agreement in which Perrigo has agreed to acquire Omega for €3.6 billion, or $4.5 billion, comprised of the purchase of Omega’s equity for €2.48 billion and the assumption of €1.1 billion in debt. The transaction, funded through a combination of cash, debt, and equity, will enhance Perrigo’s leading OTC product offering and expand its distribution through Omega’s strong established platform.
“The combination of these two great companies accelerates Perrigo’s international growth strategy, substantially diversifies our business streams and establishes a durable leadership position in the European OTC marketplace,” stated Perrigo Chairman, President and CEO Joseph C. Papa. “We believe this strategic transaction will enhance shareholder value by further strengthening our industry-leading revenue and cash flow growth profile and by expanding market opportunities. Omega brings a leading OTC product portfolio, European capabilities, and a highly experienced management team to support Perrigo’s continued growth.”